Column Group L P
- SEC CIK
- 0001347769
No open-market purchases or sales filed in the past year.
Current role at each company
- NGM NGM Biopharmaceuticals IncDirector, 10% Owneras of Apr 8, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Column Group L P as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 1, 2023 (view filing)4:31 PM ET | Jan 30-31 | 2 days | Column Group L P and 1 otherDirector, 10% Owner | PPurchase | +184.3K | $5.00 | +$921.1K | +24.8%927.2K after | 2 lotsDuplicate filing |
| Feb 1, 2023 (view filing)4:50 PM ET | Jan 30-31 | 2 days | Column Group L P and 9 othersDirector, 10% Owner | PPurchase | +184.3K | $5.00 | +$921.1K | +24.8%927.2K after | 2 lotsDuplicate filing |
| Nov 17, 2023 (view filing)4:28 PM ET | Nov 15-16 | 2 days | Column Group L P and 9 othersDirector, 10% Owner | PPurchase | +22.6K | $0.6852 | +$15.5K | +2.4%949.9K after | 2 lots |
| Nov 17, 2023 (view filing)4:30 PM ET | Nov 15-16 | 2 days | Column Group L P and 9 othersDirector, 10% Owner | PPurchase | +22.6K | $0.6852 | +$15.5K | +2.4%949.9K after | 2 lotsDuplicate filing |
| Nov 17, 2023 (view filing)4:33 PM ET | Nov 15-16 | 2 days | Column Group L P and 1 otherDirector, 10% Owner | PPurchase | +22.6K | $0.6852 | +$15.5K | +2.4%949.9K after | 2 lotsDuplicate filing |